Pharma industry is discretely working against a global tax agreement

The pharmaceutical industry is fighting against a threat to companies' bottom lines: a global agreement which will harmonize corporation tax.

French Economy and Finance Minister Bruno Le Maire | Photo: Stephane De Sakutin/AFP / AFP

The Wall Street Journal reports that pharmaceutical companies are asking that the industry should not be taxed further, reasoning that it has created vaccines against the covid-19 virus.

Top executives, lobbyists and consultants from the medical industry are mobilizing in a joint effort to combat the implementation of a global corporation tax.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Further reading

Related articles

Trial banner

Latest news

See all jobs